CS44091A3 - 1-phenylimidazole derivative, process of its preparation and use - Google Patents

1-phenylimidazole derivative, process of its preparation and use

Info

Publication number
CS44091A3
CS44091A3 CS91440A CS44091A CS44091A3 CS 44091 A3 CS44091 A3 CS 44091A3 CS 91440 A CS91440 A CS 91440A CS 44091 A CS44091 A CS 44091A CS 44091 A3 CS44091 A3 CS 44091A3
Authority
CS
Czechoslovakia
Prior art keywords
preparation
phenylimidazole derivative
phenylimidazole
derivative
Prior art date
Application number
CS91440A
Other languages
English (en)
Inventor
Hiroki Tomioka
Noriyasu Sakamoto
Kimitoshi Umeda
Hiroaki Fujimoto
Takao Ishiwatari
Hirosi Kisida
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of CS44091A3 publication Critical patent/CS44091A3/cs
Publication of CZ279536B6 publication Critical patent/CZ279536B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CS91440A 1990-06-29 1991-02-20 Derivát 1-fenylimidazolu, způsob jeho výroby a použití CZ279536B6 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17313590 1990-06-29
JP23543990 1990-09-04

Publications (2)

Publication Number Publication Date
CS44091A3 true CS44091A3 (en) 1992-02-19
CZ279536B6 CZ279536B6 (cs) 1995-05-17

Family

ID=26495230

Country Status (14)

Country Link
US (2) US5153215A (cs)
EP (2) EP0464979B1 (cs)
KR (2) KR920000745A (cs)
AU (2) AU633184B2 (cs)
BR (2) BR9100663A (cs)
CA (2) CA2036147A1 (cs)
CZ (2) CZ279634B6 (cs)
DE (2) DE69103230T2 (cs)
ES (2) ES2057754T3 (cs)
HU (2) HUT58058A (cs)
IL (2) IL97279A (cs)
MY (2) MY104627A (cs)
SK (1) SK278039B6 (cs)
YU (2) YU30391A (cs)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910021381A (ko) * 1990-02-20 1991-12-20 모리 히데오 4-3급 부틸이미다졸 유도체, 및 이의 제조방법 및 용도
CA2036147A1 (en) * 1990-06-29 1991-12-30 Hiroki Tomioka A 1-pyridylimidazole derivative and its production and use
AU644297B2 (en) * 1991-06-28 1993-12-02 Sumitomo Chemical Company, Limited A 1-pyridylimidazole derivative and its production and use
EP0599183A1 (en) * 1992-11-25 1994-06-01 Rhone-Poulenc Agrochimie Manufacturing of pesticides and intermediates
JP3715994B2 (ja) * 1993-12-21 2005-11-16 住友化学株式会社 害虫防除剤
US6413542B1 (en) 1996-03-29 2002-07-02 Merial Direct pour-on antiparasitic skin solution and methods for treating, preventing and controlling myasis
ES2359973T3 (es) * 1998-03-19 2011-05-30 MERCK SHARP & DOHME CORP. Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
US20040077703A1 (en) * 2002-10-02 2004-04-22 Soll Mark D. Nodulisporic acid derivative spot-on formulations for combating parasites
US7262214B2 (en) 2003-02-26 2007-08-28 Merial Limited 1-N-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases
US7531186B2 (en) * 2003-12-17 2009-05-12 Merial Limited Topical formulations comprising 1-N-arylpyrazole derivatives and amitraz
US20050234119A1 (en) * 2004-04-16 2005-10-20 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
US7759381B2 (en) 2006-07-05 2010-07-20 Aventis Agriculture 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
ES2614931T3 (es) * 2006-08-04 2017-06-02 Beth Israel Deaconess Medical Center Inhibidores de la piruvato cinasa y métodos de tratamiento de enfermedad
PL396375A1 (pl) 2008-11-19 2012-04-23 Merial Limited Kompozycje obejmujące arylopirazol i/lub formamidynę, sposoby i zastosowania je obejmujące
US9173728B2 (en) 2008-11-19 2015-11-03 Merial Inc. Multi-cavity container having offset indentures for dispensing fluids
JP5756457B2 (ja) * 2009-04-06 2015-07-29 アジオス ファーマシューティカルズ， インコーポレイテッド ピルビン酸キナーゼｍ２調節剤、治療組成物および関連する使用方法
EP2427441B1 (en) 2009-05-04 2016-12-14 Agios Pharmaceuticals, Inc. Pkm2 activators for use in the treatment of cancer
CA2944788C (en) 2009-06-29 2023-08-22 Agios Pharmaceuticals, Inc. Compounds, and compositions thereof, which modulate pyruvate kinase m2, and methods of making same
DK2448581T3 (en) 2009-06-29 2017-03-13 Agios Pharmaceuticals Inc Therapeutic compositions and methods for their applications
CA2784141C (en) 2009-12-17 2017-10-24 Merial Limited Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
MX2013006900A (es) 2010-12-17 2013-10-17 Agios Pharmaceuticals Inc Nuevos derivados n-(4-(azetidina-1-carbonil)fenil)-(hetero-)arilsu lfonamida como moduladores piruvato quinasa m2 (pmk2).
US9328077B2 (en) 2010-12-21 2016-05-03 Agios Pharmaceuticals, Inc Bicyclic PKM2 activators
TWI549947B (zh) 2010-12-29 2016-09-21 阿吉歐斯製藥公司 治療化合物及組成物
CN103764147B (zh) 2011-05-03 2018-05-22 安吉奥斯医药品有限公司 用于治疗的丙酮酸激酶活化剂
WO2012151440A1 (en) 2011-05-03 2012-11-08 Agios Pharmaceuticals, Inc. Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
JP6249568B2 (ja) 2011-11-17 2017-12-20 メリアル インコーポレイテッド アリールピラゾールと置換イミダゾールを含む組成物、その使用方法
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
TWI579274B (zh) 2012-04-20 2017-04-21 龍馬躍公司 製備１－芳基－５－烷基吡唑化合物的改良方法
WO2014139144A1 (en) 2013-03-15 2014-09-18 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
US10864193B2 (en) 2014-10-31 2020-12-15 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising fipronil at high concentrations
PT3307271T (pt) 2015-06-11 2023-10-10 Agios Pharmaceuticals Inc Métodos de utilização de ativadores da piruvato-cinase

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996366A (en) * 1973-11-19 1976-12-07 The Boots Company Limited Thio derivatives of imidazol-1-yl carboxamides
US4048188A (en) * 1971-12-07 1977-09-13 The Boots Company Limited 1-Carbonamido imidazoles
GB1408877A (en) * 1971-12-07 1975-10-08 Boots Co Ltd Substituted imidazoles and their use as pesticides
US3940484A (en) * 1971-12-07 1976-02-24 The Boots Company Limited Insecticidal compositions and methods of combatting insects using substituted imidazoles
US4301169A (en) * 1978-11-14 1981-11-17 Eisai Co., Ltd. Novel imidazole compound and anti-depressing agent containing the same
US4600430A (en) * 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
US4634711A (en) * 1985-08-02 1987-01-06 Smithkline Beckman Corporation Pyridylalkyl imidazole-2-thiols
DE3614364A1 (de) * 1986-04-28 1987-10-29 Hoechst Ag 1-phenyl-imidazolverbindungen, verfahren zu ihrer herstellung und ihre verwendung als wachstumsregulatoren
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
DE3811574A1 (de) * 1988-03-31 1989-10-19 Schering Ag N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
CZ284824B6 (cs) * 1989-05-05 1999-03-17 Rhone-Poulenc Agrochimie 1-Arylimidazoly, způsob jejich výroby a meziprodukty v tomto způsobu, prostředky, které je obsahují a jejich použití
KR910021381A (ko) * 1990-02-20 1991-12-20 모리 히데오 4-3급 부틸이미다졸 유도체, 및 이의 제조방법 및 용도
CA2036147A1 (en) * 1990-06-29 1991-12-30 Hiroki Tomioka A 1-pyridylimidazole derivative and its production and use

Also Published As

Publication number Publication date
DE69103230D1 (de) 1994-09-08
BR9100663A (pt) 1992-04-07
YU30491A (sh) 1994-01-20
DE69103231D1 (de) 1994-09-08
YU30391A (sh) 1994-01-20
CS44191A3 (en) 1992-02-19
BR9100662A (pt) 1992-04-07
IL97279A (en) 1994-12-29
EP0464979B1 (en) 1994-08-03
AU633184B2 (en) 1993-01-21
DE69103231T2 (de) 1994-12-15
CZ279634B6 (cs) 1995-05-17
EP0464980A1 (en) 1992-01-08
AU7118891A (en) 1992-01-02
EP0464980B1 (en) 1994-08-03
CA2036147A1 (en) 1991-12-30
SK278039B6 (en) 1995-11-08
EP0464979A1 (en) 1992-01-08
CA2036148A1 (en) 1991-12-30
HUT58059A (en) 1992-01-28
MY104627A (en) 1994-04-30
MY104626A (en) 1994-04-30
ES2057754T3 (es) 1994-10-16
AU7118691A (en) 1992-01-02
IL97279A0 (en) 1992-05-25
HU206951B (en) 1993-03-01
US5153215A (en) 1992-10-06
HUT58058A (en) 1992-01-28
HU910548D0 (en) 1991-09-30
KR920000729A (ko) 1992-01-29
HU910549D0 (en) 1991-09-30
US5122530A (en) 1992-06-16
KR920000745A (ko) 1992-01-29
IL97278A0 (en) 1992-05-25
DE69103230T2 (de) 1994-12-01
CZ279536B6 (cs) 1995-05-17
AU633183B2 (en) 1993-01-21
ES2057755T3 (es) 1994-10-16

Similar Documents

Publication Publication Date Title
CS44091A3 (en) 1-phenylimidazole derivative, process of its preparation and use
CS225991A3 (en) Substituted azoles, process of their preparation and their use
CS189391A3 (en) Dialkoxypiridylbenzimidazole derivatives, process of their preparation and their pharmaceutical use
EP0458333A3 (en) Polyisocyanato-isocyanurate, and preparation process and use of the same
CS20091A2 (en) Basic calciumaluminiumhydroxidedicarboxylate, method of its preparation and its application
CS331491A3 (en) Cyclopeptides, process of their preparation and pharmaceuticals based thereon
CS299991A3 (en) Derivatives of 2-aminopyrimidine-4-carboxamide, process of their preparation and their application as medicaments
EP0457155A3 (en) Carboxylate-ether derivatives of alkylmono- and alkylpolyglucosides, process for their preparation and their use
CS202292A3 (en) Novel pyrrolopyrazines, process of their preparation and medicaments based thereon
HU9400478D0 (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
GB2240104B (en) New arylvinylamide derivatives and process for their preparation
LTIP1406A (en) Edulcorant and its preparation process
HU9802965D0 (en) Iminothiazolidine intermediers and process for their preparation
GB9120628D0 (en) Pyrrolobenzoxazine derivatives and process for preparation thereof
IL93339A0 (en) 2,3,23-trihydroxy-urs-12-ene and its derivatives,processes for their preparation and their use
ZA916433B (en) Novel pyrrolobenzimidazoles,imidazobenzoxazinones and imidazoquinolones,process for their preparation and their use and preparations containing the compounds
CS235091A3 (en) Novel derivatives of 1-diphenylmethylpiperazine, process of their preparation and their application as medicaments
ZA911927B (en) Labdanes and process for their preparation
IL100187A0 (en) Process for the preparation of bromonitro-alcohols,dibromonitro-alcohols and mixtures thereof
CS390991A3 (en) Thiadiazinone derivatives, process of their preparation andpharmaceuticals based thereon
EP0459198A3 (en) Thioalkanones, procedure for their preparation and their use
EP0393339A3 (en) Preparation of pre-caseinates, and use
CS97892A3 (en) Adenosine derivatives, process of their preparation and therapeuticalcompositions comprising said derivatives
EP0344112A3 (en) Substituted bisacyloxynaphthacenes, and process for the preparation of tetrathiotetracenes
ZA911649B (en) 5-phenyl-1h-pyrazol-4-propionic acid derivatives,their preparation and their use